New Market - February 10, 2020
Nanoform establishes US subsidiary
Nanoform has established Nanoform USA Inc., a wholly owned subsidiary in the US. This is a natural progression for the company as it continues to increase the impact of its nanonization technology and expand its major pharma client base in the US, it states. A new Head of US sales The establishment of Nanoform USA […]
New Market - February 4, 2020
Oasmia launches its ovarian cancer treatment drug in Sweden, Denmark and Finland
Oasmia Pharmaceutical is launching its product, Apealea 60 mg, an ovarian cancer treatment drug, in Sweden, Denmark and Finland. The first batch of the drug has been shipped to distributors in these countries, states the company. Transition towards becoming a fully integrated pharmaceutical company Apealea is a patented, water-soluble, intravenously injectable formulation of paclitaxel, developed […]
New Market - January 23, 2020
LIDDS’s Nanozolid registered in the US
LIDDS has announced that the United States Patent and Trademark Office has registered the trademark NanoZolid. LIDDS thereby has exclusive rights to the trademark for products and services in the USA and in the EU, where NanoZolid has been registered since 2016. “This is an essential, although expected, step in establishing the concept of LIDDS […]
Financing - January 9, 2020
Combinostics raises €3.9 million
Finnish Combinostics has announced the closure of a €3.9 million series A funding round that will see the company scale its platform for early-stage Alzheimer’s diagnosis to the US and Asia. The round was jointly-led by Industrifonden and NordicNinja VC, with Combinostics representing NordicNinja’s fifth deep tech investment over the past 6 months. “I would […]
MedTech Business - October 16, 2019
OssDsign receives FDA clearance
The company has been granted 510(k) clearance by the US Food and Drug Administration (FDA) to market OssDsign Cranial PSI Accessories in the US. The cleared products are a set of 3D-printed, patient specific accessory devices designed to support and expand clinical use of OssDsign’s patient specific cranioplasty implant already cleared by the FDA. The […]
MedTech Business - October 4, 2019
Coala Life launches in the US
The US market launch and first patients were initiated in collaboration with Dr. Jerome Dwyer, Cardiologist, President of St. Louis Cardiology Center, P.C., and Dr. Gil Vardi, Cardiologist, Partner at St. Louis Heart and Vascular. “The Coala is a unique and smart digital solution for diagnostics of palpitations, and suspected Atrial Fibrillation, with detection anytime, […]
